Advertisement
Advertisement
Invex Therapeutics Ltd Faces ASX Suspension Over Governance Issues
PremiumCompany AnnouncementsInvex Therapeutics Ltd Faces ASX Suspension Over Governance Issues
7d ago
Invex Therapeutics Reports Promising Alzheimer’s Research with Exenatide
Premium
Company Announcements
Invex Therapeutics Reports Promising Alzheimer’s Research with Exenatide
11d ago
Invex Therapeutics to Hold Virtual Annual General Meeting
Premium
Company Announcements
Invex Therapeutics to Hold Virtual Annual General Meeting
21d ago
Invex Therapeutics Halts Negotiations Amid Board Instability
PremiumCompany AnnouncementsInvex Therapeutics Halts Negotiations Amid Board Instability
2M ago
Invex Therapeutics Announces AGM Date and Director Nomination Deadline
Premium
Company Announcements
Invex Therapeutics Announces AGM Date and Director Nomination Deadline
2M ago
Invex Therapeutics Seeks Extension on Trading Suspension Amid Pending Announcement
Premium
Company Announcements
Invex Therapeutics Seeks Extension on Trading Suspension Amid Pending Announcement
2M ago
Invex Therapeutics Reports Financial Downturn Amid Strategic Reassessment
PremiumCompany AnnouncementsInvex Therapeutics Reports Financial Downturn Amid Strategic Reassessment
3M ago
Invex Therapeutics Expands Research and Streamlines Operations
Premium
Company Announcements
Invex Therapeutics Expands Research and Streamlines Operations
4M ago
Invex Therapeutics Expands Alzheimer’s Research Collaboration and Reports Financial Stability
Premium
Company Announcements
Invex Therapeutics Expands Alzheimer’s Research Collaboration and Reports Financial Stability
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100